SNCA and Parkinson disease: However, in PD, this balance tips toward inflammation, as ROCK1/ROCK2-mediated cytoskeletal changes impair microglial clearance of α-synuclein (STAT3/α-synuclein interaction), leading to reduced anti-inflammatory signaling (e.g., via extensive transcriptional signaling).